How to Reduce Inflammation Naturally
Chronic inflammation is increasingly recognized as a root cause of many modern diseases. A 2019 Nature Medicine study reported that chronic inflammation predicts mortality risk more accurately than traditional markers like cholesterol or blood pressure. Understanding how to reduce inflammation at the cellular level is essential for long-term health.
Why Inflammation Matters
When tissue damage or infection occurs, pattern recognition receptors on immune cells detect injury signals. This triggers NF-kB inflammatory signaling, causing cells to release inflammatory cytokines. These cytokines:
- Dilate blood vessels (causing redness)
- Increase vascular permeability (causing swelling)
- Recruit immune cells to the area (producing pain)
While acute inflammation is protective, chronic inflammation damages tissues, impairs cellular function, and contributes to conditions ranging from heart disease to neurodegeneration.
Peptides Researched for Inflammation
BPC-157
Long-term low-dose BPC-157 creates what researchers call "biological memory" for resolving inflammation. A 2018 Sikiric study showed it expands regulatory T-cell populations - cells that tell the immune system when to stop fighting. This creates immune tolerance: your immune system learns when to stop attacking.
BPC-157 also activates mitophagy (mitochondrial quality control), removing damaged mitochondria and generating healthy new ones. This improves ATP production and NAD+ metabolism. As mitochondrial quality improves, SIRTuin activation follows.
KPV
KPV directly inhibits NF-kB, suppressing inflammatory cytokine production at the source. With inflammatory cytokines reduced, inflammasome signaling normalizes. Studies suggest improvements in glucose uptake when inflammatory signaling is reduced.
In the brain, chronic inflammation activates microglia (the immune cells of the nervous system). KPV is described as reducing microglial NF-kB activation in research models, potentially protecting against neuroinflammation.
Retatrutide
Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors. For inflammation, it works through multiple pathways:
- GLP-1 signaling increases IL-10, TGF-beta, and regulatory T cells (anti-inflammatory)
- GIP signaling supports gut barrier integrity
- Glucagon signaling activates autophagy to remove damaged cellular components
A 2024 Nature Aging analysis found that 52 weeks of retatrutide showed a 2.3-year reversal in epigenetic aging markers - cells appeared biologically younger.
The Three Drivers of Chronic Disease
Research suggests that most chronic diseases share three biological drivers:
- Inflammation - persistent immune activation that damages tissues
- Insulin resistance - impaired cellular response to insulin
- ATP shortage - mitochondrial dysfunction limiting cellular energy
Peptides that address multiple drivers simultaneously may offer more comprehensive support than single-target approaches.
Search Our Knowledge Base
Explore 200+ conditions and 37 peptides with AI-powered analysis.
Open Knowledge Base